Home › NDC Lookup › Ingredients › Octinoxate, Titanium Dioxide And Zinc Ox... › 43419-0077-31
SULWHASOO PERFECTING CUSHION NO. 21 OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE 2.1 g/30g; 1.245 g/30g; 2.94 g/30g Lotion — NDC 43419-0077-31 package photo

SULWHASOO PERFECTING CUSHION NO. 21 OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE 2.1 g/30g; 1.245 g/30g; 2.94 g/30g Lotion

by Amorepacific Corporation · 2 CONTAINER in 1 CARTON (43419-077-31) / 15 g in 1 CONTAINER
NDC 43419-0077-31
🏷️ FDA NDC (as labeled) 43419-077-31 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 43419-077-31
Product NDC 43419-077
11-digit billing NDC 43419007731
UNII 4Y5P7MUD51, SOI2LOH54Z, 15FIX9V2JP
Application # M020
SPL Set ID 8d420e4b-c778-3ed4-e053-2995a90a59a9
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-07-15
Marketing end 2027-07-31
Route TOPICAL
Dosage form LOTION
Substance OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
Why two NDCs? The FDA registers this code as 43419-077-31 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 43419-0077-31. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerAmorepacific Corporation
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code43419
First marketedJul 2019
Product typeHuman Otc Drug
Portfolio34 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is a topical lotion cushion product marketed as an over-the-counter monograph drug. It contains three active ingredients that function as inorganic sunscreen agents: octinoxate, titanium dioxide, and zinc oxide are typically used together to help protect skin from ultraviolet (UV) light exposure when applied to the face. Products of this type are commonly used as part of a daily skincare routine to shield skin from sun damage.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sulwhasoo Perfecting Cushion No. 25 2.1 g/30g; 1.245 g/30g; 2.94 g/30g 43419-0079-31 Amorepacific 15 g — — FDA listed —
Sulwhasoo Perfecting Cushion No. 23 2.1 g/30g; 1.245 g/30g; 2.94 g/30g 43419-0078-31 Amorepacific 15 g — — FDA listed —
Sulwhasoo Perfecting Cushion No. 21 2.1 g/30g; 1.245 g/30g; 2.94 g/30gthis 43419-0077-31 Amorepacific 15 g — — FDA listed —
Sulwhasoo Perfecting Cushion No. 15 2.1 g/30g; 1.245 g/30g; 2.94 g/30g 43419-0075-31 Amorepacific 15 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2019
On the market since
Jul 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
43419-0077-31 You're viewing this 2 CONTAINER in 1 CARTON (43419-077-31) / 15 g in 1 CONTAINER 2019-07-15 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 43419-077-31, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 43419-0077-31, written without dashes as 43419007731. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 43419-0077-31, the first segment (43419) is the labeler code FDA assigned to Amorepacific Corporation; the middle segment (0077) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (31) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Amorepacific Corporation has reported a marketing end date of 2027-07-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Amorepacific Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 30 words ▾

USES Helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

⏱️ Dosage and Administration 94 words ▾

DIRECTIONS Apply liberally 15 minutes before sun exposure Children under 6 months of age : Ask a doctor. Reapply at least every 2 hours. Use a water-resistant sunscreen if swimming or sweating.

Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including : Limit time in the sun, especially from 10 a.m. - 2 p.m.

Wear long-sleeved shirts, pants, hats, and sunglasses.

⚠️ Warnings 54 words ▾

WARNINGS For external use only Do not use on broken skin. When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

📦 Storage and Handling 42 words ▾

OTHER INFORMATION Protect the product in this container from excessive heat and direct sun. Sun alert : Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risks of skin aging, skin cancer, and other harmful effects of the sun.

🧪 Active Ingredient 11 words ▾

ACTIVE INGREDIENTS W/W OCTINOXATE 7% TITANIUM DIOXIDE 4.15% ZINC OXIDE 9.8%

🧪 Inactive Ingredients 116 words ▾

INACTIVE INGREDIENTS Water / Aqua / Eau, Cyclopentasiloxane, Titanium Dioxide (CI 77891), Cyclohexasiloxane, Phenyl Trimethicone, PEG-10 Dimethicone, Butylene Glycol Dicaprylate/Dicaprate, Niacinamide, Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone, Glycerin, Propanediol, Acrylates/Ethylhexyl Acrylate/Dimethicone Methacrylate Copolymer, Polymethyl Methacrylate, Polyhydroxystearic Acid, Iron Oxides (CI 77492), Aluminum Hydroxide, Sodium Chloride, Trimethylsiloxysilicate, Stearic Acid, Triethoxycaprylylsilane, Fragrance / Parfum, Disteardimonium Hectorite, Butylene Glycol, Ethylhexyl Palmitate, Lecithin, Isostearic Acid, Isopropyl Palmitate, Polysorbate 80, Caprylyl Glycol, Iron Oxides (CI 77491), Hydrogenated Lecithin, Polyglyceryl-3 Polyricinoleate, Ethylhexylglycerin, Glyceryl Caprylate, Iron Oxides (CI 77499), Disodium EDTA, Adenosine, Honey / Mel / Miel, Acrylates/VP Copolymer, Nelumbo Nucifera Flower Extract, Polygonatum Officinale Rhizome/Root Extract, Rehmannia Glutinosa Root Extract, Paeonia Albiflora Root Extract, Lilium Candidum Bulb Extract, Beta-Glucan, Alcohol, Phenoxyethanol, Tocopherol, Sodium Hyaluronate

🎯 Purpose 2 words ▾

PURPOSE Sunscreen

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 43419-0075-31 · Amorepacific 43419-0078-31 · Amorepacific →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.